New insights on interactions between HIV-1 and HSV-2

被引：13

作者：

Delany-Moretlwe S. ^{[1
]}

Lingappa J.R. ^{[1
]}

Celum C. ^{[1
]}

机构：

[1] Reproductive Health and HIV Research Unit, University of Witwatersrand, Hillbrow, Johannesburg 2038

来源：

Current Infectious Disease Reports | 2009年 / 11卷 / 2期

关键词：

Acyclovir;

D O I：

10.1007/s11908-009-0020-8

中图分类号：

学科分类号：

摘要：

Herpes simplex type 2 (HSV-2) infection is common and frequently asymptomatic. Concerns exist about the high prevalence of HSV-2, particularly in areas of high HIV prevalence, because of observations that HSV-2 is associated with an increased risk of HIV acquisition, transmission, and disease progression. Several randomized trials have tested or are testing whether HSV-2 treatment can limit the spread of HIV, with mixed results. Although treatment with acyclovir, 400 mg twice daily, does not reduce HIV incidence, suppressive acyclovir and valacyclovir reduce HIV levels in plasma and in the genital tract. Ongoing trials are evaluating whether HSV suppression will reduce HIV transmission and disease progression. Until a protective HSV-2 or HIV vaccine is available, effective interventions that reduce the effect of HSV-2 on HIV transmission are critically needed. © Current Medicine Group, LLC 2009.

引用

页码：135 / 142

页数：7

共 58 条

[21]

Schacker T., Ryncarz A.J., Goddard J., Et al., Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men, JAMA, 280, pp. 61-66, (1998)

[22]

Mole L., Ripich S., Margolis D., Holodniy M., The impact of active herpes simplex virus infection on human immunodeficiency virus load, J Infect Dis, 176, pp. 766-770, (1997)

[23]

McClelland R.S., Wang C.C., Overbaugh J., Et al., Association between cervical shedding of herpes simplex virus and HIV-1, AIDS, 16, pp. 2425-2430, (2002)

[24]

Diaz J.J., Dodon M.D., Schaerer-Uthurralt N., Et al., Post-transcriptional transactivation of human retroviral envelope glycoprotein expression by herpes simplex virus Us11 protein, Nature, 379, pp. 273-277, (1996)

[25]

Margolis D.M., Rabson A.B., Straus S.E., Ostrove J.M., Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes, Virology, 186, pp. 788-791, (1992)

[26]

Mosca J.D., Bednarik D.P., Raj N.B., Et al., Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus, Nature, 325, pp. 67-70, (1987)

[27]

Heng M.C., Heng S.Y., Allen S.G., Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1, Lancet, 343, pp. 255-258, (1994)

[28]

Kucera L.S., Leake E., Iyer N., Et al., Human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 2 (HSV-2) can coinfect and simultaneously replicate in the same human CD4+ cell: Effect of coinfection on infectious HSV-2 and HIV-1 replication, AIDS Res Hum Retroviruses, 6, pp. 641-647, (1990)

[29]

Clouse K.A., Powell D., Washington I., Et al., Monokine regulation of human immune deficiency virus type 1 expression in a chronically infected human t-cell line, J Immunol, 142, pp. 431-438, (1989)

[30]

Paludan S.R., Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes, J Virol, 75, pp. 8008-8015, (2001)

← 1 2 3 4 5 6 →